HT
DGX icon

Headlands Technologies’s Quest Diagnostics DGX Stock Holding History

Headlands Technologies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-950
Closed -$171K – 774
2025
Q2 		$171K Buy
+950
New +$165K 0.02% 518
2024
Q4 		– Sell
-114
Closed -$17.7K – 1272
2024
Q3 		$17.7K Sell
114
-2,081
-95% -$311K ﹤0.01% 960
2024
Q2 		$300K Buy
2,195
+1,048
+91% +$144K 0.03% 385
2024
Q1 		$153K Buy
+1,147
New +$149K 0.04% 443
2023
Q4 		– Sell
-153
Closed -$18.6K – 1018
2023
Q3 		$18.6K Buy
+153
New +$20.4K 0.01% 598

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Headlands Technologies's DGX Position: Q3 2025 in Review

Headlands Technologies sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 950 shares — an estimated $171K sold.

Headlands Technologies first reported a position in DGX in Q3 2023 and held it in 5 quarters. The position peaked at $300K in Q2 2024. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Headlands Technologies reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 950 Quest Diagnostics shares in Q3 2025, an estimated $171K.
  • Headlands Technologies first reported a position in Quest Diagnostics in Q3 2023 and held it in 5 quarters.
  • Headlands Technologies's Quest Diagnostics position peaked at $300K in Q2 2024.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.